Insignia Financial Valuation

Is IOH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of IOH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: IOH (€1.89) is trading below our estimate of fair value (€4.52)

Significantly Below Fair Value: IOH is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for IOH?

Key metric: As IOH is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for IOH. This is calculated by dividing IOH's market cap by their current revenue.
What is IOH's PS Ratio?
PS Ratio1.1x
SalesAU$1.94b
Market CapAU$2.08b

Price to Sales Ratio vs Peers

How does IOH's PS Ratio compare to its peers?

The above table shows the PS ratio for IOH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.4x
MLP MLP
0.6x2.3%€640.5m
MUX Mutares SE KGaA
0.09x10.5%€494.3m
AR4 AURELIUS Equity Opportunities SE KGaA
0.1xn/a€389.6m
O4B OVB Holding
0.7x3.9%€283.6m
IOH Insignia Financial
1.1x-7.0%€2.1b

Price-To-Sales vs Peers: IOH is expensive based on its Price-To-Sales Ratio (1.1x) compared to the peer average (0.4x).


Price to Sales Ratio vs Industry

How does IOH's PS Ratio compare vs other companies in the DE Capital Markets Industry?

22 CompaniesPrice / SalesEstimated GrowthMarket Cap
MLP MLP
0.6x2.3%US$677.33m
MUX Mutares SE KGaA
0.09x10.5%US$522.69m
AR4 AURELIUS Equity Opportunities SE KGaA
0.2x0.01%US$500.05m
AR4 AURELIUS Equity Opportunities SE KGaA
0.1xn/aUS$411.59m
IOH 1.1xIndustry Avg. 2.9xNo. of Companies22PS048121620+
22 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: IOH is good value based on its Price-To-Sales Ratio (1.1x) compared to the German Capital Markets industry average (2.8x).


Price to Sales Ratio vs Fair Ratio

What is IOH's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

IOH PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.1x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate IOH's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst IOH forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€1.89
€2.11
+12.0%
11.7%€2.64€1.64n/a10
Nov ’25€1.95
€1.95
+0.2%
14.8%€2.52€1.34n/a10
Oct ’25n/a
€1.76
0%
15.2%€2.23€1.37n/a10
Sep ’25n/a
€1.77
0%
16.4%€2.24€1.34n/a11
Aug ’25n/a
€1.76
0%
17.7%€2.22€1.36n/a11
Jul ’25n/a
€1.75
0%
18.4%€2.26€1.35n/a11
Jun ’25n/a
€1.75
0%
18.4%€2.26€1.35n/a11
May ’25n/a
€1.77
0%
18.2%€2.24€1.34n/a10
Apr ’25n/a
€1.74
0%
18.3%€2.23€1.33n/a10
Mar ’25n/a
€1.74
0%
18.3%€2.23€1.33n/a10
Feb ’25n/a
€1.57
0%
18.8%€2.07€1.25n/a9
Jan ’25n/a
€1.55
0%
18.8%€2.06€1.21n/a9
Dec ’24n/a
€1.55
0%
18.8%€2.06€1.21n/a9
Nov ’24n/a
€1.53
0%
18.8%€2.04€1.20€1.959
Oct ’24n/a
€1.83
0%
13.8%€2.31€1.52n/a9
Sep ’24n/a
€1.94
0%
20.0%€2.62€1.48n/a11
Aug ’24n/a
€2.29
0%
12.7%€2.75€1.89n/a11
Jul ’24n/a
€2.24
0%
11.7%€2.65€1.89n/a11
Jun ’24n/a
€2.24
0%
11.7%€2.65€1.89n/a11
May ’24n/a
€2.24
0%
11.7%€2.65€1.89n/a11
Apr ’24n/a
€2.48
0%
8.8%€2.81€2.13n/a11
Mar ’24n/a
€2.57
0%
12.8%€3.37€2.16n/a11
Feb ’24n/a
€2.62
0%
12.2%€3.44€2.21n/a11
Jan ’24n/a
€2.52
0%
15.1%€3.42€2.10n/a11
Dec ’23n/a
€2.52
0%
15.1%€3.42€2.10n/a11
Nov ’23n/a
€2.56
0%
14.9%€3.41€2.09n/a10

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies